P3 Health Partners Operating Income 2020-2024 | PIII
P3 Health Partners operating income from 2020 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| P3 Health Partners Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-168 |
| 2022 | $-1,561 |
| 2021 | $-188 |
| 2020 | $-29 |
| 2019 | $-40 |
| P3 Health Partners Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-44 |
| 2023-12-31 | $-64 |
| 2023-09-30 | $-34 |
| 2023-06-30 | $-21 |
| 2023-03-31 | $-49 |
| 2022-12-31 | $-537 |
| 2022-09-30 | $-60 |
| 2022-06-30 | $-912 |
| 2022-03-31 | $-52 |
| 2021-12-31 | $-121 |
| 2021-09-30 | $-28 |
| 2021-06-30 | $-26 |
| 2021-03-31 | $-13 |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.231B | $1.266B |
| P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.763B | 20.73 |
| Inspire Medical Systems (INSP) | United States | $5.181B | 0.00 |
| Axonics (AXNX) | United States | $3.439B | 0.00 |
| 10x Genomics (TXG) | United States | $3.145B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.107B | 0.00 |
| Azenta (AZTA) | United States | $2.928B | 159.12 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.910B | 0.00 |
| Enovis (ENOV) | United States | $2.800B | 20.75 |
| Hims & Hers Health (HIMS) | United States | $2.768B | 0.00 |
| Privia Health (PRVA) | United States | $2.139B | 120.20 |
| Schrodinger (SDGR) | United States | $1.673B | 0.00 |
| Omnicell (OMCL) | United States | $1.389B | 48.02 |
| Phreesia (PHR) | United States | $1.238B | 0.00 |
| Standard BioTools (LAB) | United States | $0.699B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.652B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.610B | 0.00 |
| Talkspace (TALK) | United States | $0.483B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.428B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.394B | 0.00 |
| Pulmonx (LUNG) | United States | $0.340B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.314B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.205B | 0.00 |
| Outset Medical (OM) | United States | $0.169B | 0.00 |
| American Well (AMWL) | United States | $0.152B | 0.00 |
| TruBridge (TBRG) | United States | $0.123B | 5.26 |
| Augmedix (AUGX) | United States | $0.122B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.095B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.073B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.060B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| Movano (MOVE) | United States | $0.039B | 0.00 |
| Akili (AKLI) | United States | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| CareCloud (CCLD) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |